Matches in SemOpenAlex for { <https://semopenalex.org/work/W4303520829> ?p ?o ?g. }
- W4303520829 endingPage "447" @default.
- W4303520829 startingPage "442" @default.
- W4303520829 abstract "Non-alcoholic fatty liver disease is a condition that affects 25% of the population. Non-alcoholic steatohepatitis (NASH) is a progressive form of the disease that can lead to severe complications such as cirrhosis and hepatocellular carcinoma. Despite its high prevalence, no drugs are currently approved for the treatment of NASH. The drug development pipeline in NASH is very active, yet most assets do not progress to phase III trials and those that do reach phase III often fail to achieve the endpoints necessary for approval by regulatory agencies. Amongst other reasons, the methodological and operational features of traditional clinical trials in NASH might impede optimal drug development. In this regard, platform trials might be an attractive complement or alternative to conventional clinical trials. Platform trials use a master protocol which enables evaluation of multiple investigational medicinal products concurrently or sequentially with a single, shared control arm. Through Bayesian interim analyses, these trials allow for early exit of drugs from the trial based on success or futility, while providing participants better chances of receiving active compounds through adaptive randomisation. Overall, platform trials represent an alternative for patients, pharmaceutical companies, and clinicians in the quest to accelerate the approval of pharmacologic treatments for NASH." @default.
- W4303520829 created "2022-10-08" @default.
- W4303520829 creator A5000704666 @default.
- W4303520829 creator A5002662600 @default.
- W4303520829 creator A5005595299 @default.
- W4303520829 creator A5005996725 @default.
- W4303520829 creator A5010443326 @default.
- W4303520829 creator A5011290739 @default.
- W4303520829 creator A5012035250 @default.
- W4303520829 creator A5017470955 @default.
- W4303520829 creator A5018682188 @default.
- W4303520829 creator A5020115149 @default.
- W4303520829 creator A5021659336 @default.
- W4303520829 creator A5025280404 @default.
- W4303520829 creator A5028206881 @default.
- W4303520829 creator A5028573699 @default.
- W4303520829 creator A5035862461 @default.
- W4303520829 creator A5039059881 @default.
- W4303520829 creator A5040042807 @default.
- W4303520829 creator A5041412117 @default.
- W4303520829 creator A5043337328 @default.
- W4303520829 creator A5047027997 @default.
- W4303520829 creator A5054187872 @default.
- W4303520829 creator A5054324731 @default.
- W4303520829 creator A5057977784 @default.
- W4303520829 creator A5059068278 @default.
- W4303520829 creator A5059256325 @default.
- W4303520829 creator A5060309242 @default.
- W4303520829 creator A5065409879 @default.
- W4303520829 creator A5083825910 @default.
- W4303520829 date "2023-02-01" @default.
- W4303520829 modified "2023-10-17" @default.
- W4303520829 title "Platform trials to overcome major shortcomings of traditional clinical trials in non-alcoholic steatohepatitis? Pros and cons" @default.
- W4303520829 cites W1969100385 @default.
- W4303520829 cites W1997425045 @default.
- W4303520829 cites W2005494948 @default.
- W4303520829 cites W2091106363 @default.
- W4303520829 cites W2096817075 @default.
- W4303520829 cites W2105805568 @default.
- W4303520829 cites W2108247235 @default.
- W4303520829 cites W2277891177 @default.
- W4303520829 cites W2573090827 @default.
- W4303520829 cites W2726405642 @default.
- W4303520829 cites W2734724639 @default.
- W4303520829 cites W2889932786 @default.
- W4303520829 cites W2896941758 @default.
- W4303520829 cites W2958296451 @default.
- W4303520829 cites W2973459418 @default.
- W4303520829 cites W2996864845 @default.
- W4303520829 cites W3023600519 @default.
- W4303520829 cites W3027827688 @default.
- W4303520829 cites W3037894148 @default.
- W4303520829 cites W3038092240 @default.
- W4303520829 cites W3040508995 @default.
- W4303520829 cites W3094978149 @default.
- W4303520829 cites W3101728747 @default.
- W4303520829 cites W3118968942 @default.
- W4303520829 cites W3161701468 @default.
- W4303520829 cites W3197814387 @default.
- W4303520829 cites W3201178869 @default.
- W4303520829 cites W3213674978 @default.
- W4303520829 cites W4206982035 @default.
- W4303520829 cites W4223941107 @default.
- W4303520829 cites W4280622190 @default.
- W4303520829 doi "https://doi.org/10.1016/j.jhep.2022.09.021" @default.
- W4303520829 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36216134" @default.
- W4303520829 hasPublicationYear "2023" @default.
- W4303520829 type Work @default.
- W4303520829 citedByCount "6" @default.
- W4303520829 countsByYear W43035208292022 @default.
- W4303520829 countsByYear W43035208292023 @default.
- W4303520829 crossrefType "journal-article" @default.
- W4303520829 hasAuthorship W4303520829A5000704666 @default.
- W4303520829 hasAuthorship W4303520829A5002662600 @default.
- W4303520829 hasAuthorship W4303520829A5005595299 @default.
- W4303520829 hasAuthorship W4303520829A5005996725 @default.
- W4303520829 hasAuthorship W4303520829A5010443326 @default.
- W4303520829 hasAuthorship W4303520829A5011290739 @default.
- W4303520829 hasAuthorship W4303520829A5012035250 @default.
- W4303520829 hasAuthorship W4303520829A5017470955 @default.
- W4303520829 hasAuthorship W4303520829A5018682188 @default.
- W4303520829 hasAuthorship W4303520829A5020115149 @default.
- W4303520829 hasAuthorship W4303520829A5021659336 @default.
- W4303520829 hasAuthorship W4303520829A5025280404 @default.
- W4303520829 hasAuthorship W4303520829A5028206881 @default.
- W4303520829 hasAuthorship W4303520829A5028573699 @default.
- W4303520829 hasAuthorship W4303520829A5035862461 @default.
- W4303520829 hasAuthorship W4303520829A5039059881 @default.
- W4303520829 hasAuthorship W4303520829A5040042807 @default.
- W4303520829 hasAuthorship W4303520829A5041412117 @default.
- W4303520829 hasAuthorship W4303520829A5043337328 @default.
- W4303520829 hasAuthorship W4303520829A5047027997 @default.
- W4303520829 hasAuthorship W4303520829A5054187872 @default.
- W4303520829 hasAuthorship W4303520829A5054324731 @default.
- W4303520829 hasAuthorship W4303520829A5057977784 @default.
- W4303520829 hasAuthorship W4303520829A5059068278 @default.
- W4303520829 hasAuthorship W4303520829A5059256325 @default.
- W4303520829 hasAuthorship W4303520829A5060309242 @default.